Evidence map›Paper›PMID 28085500›Full record

ArticleAmerican journal of respiratory and critical care medicine2017

A Pilot Study Linking Endothelial Injury in Lungs and Kidneys in Chronic Obstructive Pulmonary Disease.

Francesca Polverino, Maria E Laucho-Contreras, Hans Petersen, Vanesa Bijol, Lynette M Sholl, Mary E Choi, Miguel Divo, Victor Pinto-Plata, Alfredo Chetta, Yohannes Tesfaigzi and 2 more

Abstract read
In one paragraph

Article in American journal of respiratory and critical care medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 2 pooled it
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 2 syntheses or guidelines pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Receptor for advanced glycation end-products and environmental exposure related obstructive airways disease: a systematic review.European respiratory review : an official journal of the European Respiratory Society · 2019
    Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Does Chronic Obstructive Pulmonary Disease Originate from Different Cell Types?American journal of respiratory cell and molecular biology · 2023
    Article
  12. Review
  13. Selecting the Right Patient: The Achilles Heel of COPD Clinical Trials.American journal of respiratory and critical care medicine · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Kidney and lung in pathology: mechanisms and clinical implications.Multidisciplinary respiratory medicine · 2022
    Article
  19. Article
  20. Metformin: Experimental and Clinical Evidence for a Potential Role in Emphysema Treatment.American journal of respiratory and critical care medicine · 2021
    Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Francesca Polverino1 Pulmonary Division and.ORCID 0000-0001-9686-5698
Maria E Laucho-Contreras4 Universidad Central de Venezuela, Caracas, Venezuela; and.
Hans Petersen2 Lovelace Respiratory Research Institute, Albuquerque, New Mexico.
Vanesa Bijol5 Pathology Department, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Lynette M Sholl5 Pathology Department, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Mary E Choi6 Nephrology Division, Weill Cornell Medical College, New York, New York.
Miguel Divo1 Pulmonary Division and.
Victor Pinto-Plata1 Pulmonary Division and.
Alfredo Chetta3 University of Parma, Parma, Italy.
Yohannes Tesfaigzi2 Lovelace Respiratory Research Institute, Albuquerque, New Mexico.
Bartolomé R Celli1 Pulmonary Division and.
Caroline A Owen1 Pulmonary Division and.ORCID 0000-0003-4377-3591
Lovelace Respiratory Research Institute · USBrigham and Women's Hospital · USUniversity of Parma · ITCentral University of Venezuela · VECornell University · US

Funding

Respiratory Computational Discovery CoreP01HL114501 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI CHOI, MARY E · 2013 to 2025
$24.9M
Systems Biology, Bioinformatics, and BiostatisticsP01HL105339 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2011 to 2015
$12.2M
HEME OXYGENASE 1--LUNG VASCULAR CELL HYPOXIC RESPONSER01HL060234 · NHLBI · YALE UNIVERSITY · PI CHOI, AUGUSTINE M, CHOI, MARY E · 1999 to 2017
$5.8M
Targeting MMP9 to Improve Outcomes in Serious Influenza InfectionsR01AI111475 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HARROD, KEVIN S, LEVY, BRUCE D · 2014 to 2018
$4.3M
TGF-beta signaling in the kidneyR01DK057661 · NIDDK · YALE UNIVERSITY · PI CHOI, MARY E · 2000 to 2014
$4.1M
Novel Roles for MMP-8 in Acute Lung InjuryR01HL063137 · NHLBI · UNIVERSITY OF UTAH · PI OWEN, CAROLINE A · 1999 to 2008
$2.6M
Novel Roles for ADAM15 in Acute Lung InjuryR01HL086814 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI OWEN, CAROLINE A · 2007 to 2010
$1.6M
Novel Anti-inflammatory Activities For ADAM8 In Pulmonary EmphysemaR21HL111835 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI OWEN, CAROLINE A · 2012 to 2013
$456k
NHLBI NIH HHS P01 HL105339NHLBI NIH HHS P01 HL114501NHLBI NIH HHS R01 HL060234NHLBI NIH HHS R01 HL063137NHLBI NIH HHS R01 HL086814NHLBI NIH HHS R21 HL111835NIAID NIH HHS R01 AI111475NIDDK NIH HHS R01 DK057661
6 · The paper itself

Abstract

rationalePatients with chronic obstructive pulmonary disease (COPD) frequently have albuminuria (indicative of renal endothelial cell injury) associated with hypoxemia.

objectivesTo determine whether (1) cigarette smoke (CS)-induced pulmonary and renal endothelial cell injury explains the association between albuminuria and COPD, (2) CS-induced albuminuria is linked to increases in the oxidative stress-advanced glycation end products (AGEs) receptor for AGEs (RAGE) pathway, and (3) enalapril (which has antioxidant properties) limits the progression of pulmonary and renal injury by reducing activation of the AGEs-RAGE pathway in endothelial cells in both organs.

methodsIn 26 patients with COPD, 24 ever-smokers without COPD, 32 nonsmokers who underwent a renal biopsy or nephrectomy, and in CS-exposed mice, we assessed pathologic and ultrastructural renal lesions, and measured urinary albumin/creatinine ratios, tissue oxidative stress levels, and AGEs and RAGE levels in pulmonary and renal endothelial cells. The efficacy of enalapril on pulmonary and renal lesions was assessed in CS-exposed mice. MEASUREMENTS AND MAIN

resultsPatients with COPD and/or CS-exposed mice had chronic renal injury, increased urinary albumin/creatinine ratios, and increased tissue oxidative stress and AGEs-RAGE levels in pulmonary and renal endothelial cells. Treating mice with enalapril attenuated CS-induced increases in urinary albumin/creatinine ratios, tissue oxidative stress levels, endothelial cell AGEs and RAGE levels, pulmonary and renal cell apoptosis, and the progression of chronic renal and pulmonary lesions.

conclusionsPatients with COPD and/or CS-exposed mice have pulmonary and renal endothelial cell injury linked to increased endothelial cell AGEs and RAGE levels. Albuminuria could identify patients with COPD in whom angiotensin-converting enzyme inhibitor therapy improves renal and lung function by reducing endothelial injury.

Indexed as

AgedAnimalsDisease Models, AnimalEndotheliumFemaleHumansKidneyLungMaleMiceMice, Inbred C57BLMiddle AgedOxidative StressPilot ProjectsPulmonary Disease, Chronic Obstructivecigarette smokecomorbiditiesCOPDendotheliumkidney

Identifiers

PMID28085500
PMCPMC5470750
OpenAlexW2587650424

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.